Efficient gene transfer into human hematopoietic stem cells (HSCs) is the most important requirement for gene therapy of hematopoietic disorders and for study of the hematopoietic system. An adenovirus (Ad) vector based on the Ad serotype 5 (Ad5) is known to transduce HSCs, including CD34 + cells, with very low efficiency because of low-level expression of its primary receptor, coxsackievirus and adenovirus receptor (CAR). In the present study, we developed a recombinant Ad vector composed of the whole Ad serotype 35 (Ad35), which recognizes an unidentified receptor different from CAR for its infection. A transduction study showed that the Ad35-based vectors exhibit a higher transduction efficiency in human CD34 + cells than the conventional Ad5 vectors and the Ad5F35 vectors, which are fiber-substituted Ad5 vectors containing Ad35 fiber proteins. The mean of fluorescence intensity in the CD34 + cells transduced with the Ad35 vectors was 12-76 and 1.4-3 times higher than that in the cells transduced with the Ad5 and Ad5F35 vectors, respectively. The percentages of green fluorescent protein (GFP)-positive CD34 + cells by transduction with Ad35, Ad5, and Ad5F35 vectors expressing GFP at 300 PFU/cell were 53%, 5%, and 52%, respectively, suggesting that Ad35 vectors mediate a more efficient gene transfer into human CD34 + cells than Ad5 and Ad5F35 vectors, although the percentage of transduced cells was similar between Ad35 and Ad5F35 vectors. The Ad vector based on Ad35 could be very useful in gene therapy for blood disorders and gene transfer experiments using HSCs.
Introduction
Human hematopoietic stem cells (HSCs) are an important target in gene therapy for hematopoietic disorders. Efficient gene transfer into HSCs also provides a powerful tool for the study of gene function in HSCs. However, CD34 + -enriched bone marrow cells, which contain an HSC population, are almost refractory to transduction by most virus vectors because of their quiescent state and the lack of corresponding receptors for virus binding. 1, 2 Transduction of HSCs by commonly used Ad vectors based on serotype 2 and 5, which belong to subgroup C, is also inefficient. The limiting factor is the scarcity of their primary receptor, coxsakievirus and adenovirus receptor (CAR) in HSCs. 3, 4 Ad serotype 35 (Ad35), which belongs to subgroup B, has been primarily isolated from the kidneys and lungs of a renal transplant patient. 5 Ad35 uses unidentified receptors different from CAR, and it has been reported that Ad35 interacts with human CD34 + cells and cultured blood cell lines more efficiently than Ad5. 6, 7 We and other groups have reported that a fiber-substituted Ad vector (Ad5F35), which contains the Ad35 fiber knob and shaft, instead of the Ad5 fiber knob and shaft, incorporated into the Ad5 capsid, exhibits a higher transduction efficiency in human CD34 + cells and culture blood cells than the Ad5 vector. [7] [8] [9] [10] The transduction efficiencies of other types of fiber-substituted Ad vectors containing the fiber knob and shaft of Ad16 or Ad50 in human CD34 + cells were also found to be higher than that of the Ad5 vector. 8 It is an attractive approach to the retargeting of Ad tropism to swap part or all of the fiber from one serotype to another. However, we found the transgene expression levels by Ad5F35 vector to be still lower than we had expected, as Ad35 showed a much more efficient attachment to blood cells than Ad5. 6 We speculated that the Ad vector composed of whole Ad35 would transduce HSCs more efficiently than the Ad5F35 vector because viral intracellular trafficking would depend on the structural capsid proteins, and that the appropriate arrangement of fiber proteins, a penton base, and hexon might be critical to retain the natural infectious activity. We therefore developed a replication-defective Ad vector based on serotype 35 and compared its gene transfer activity into human CD34 + cells with that of Ad5F35 and conventional Ad vector based on Ad5.
Construction of the recombinant Ad35 vector
Ad35 (VR-718), which was obtained from ATCC (Rockville, MD, USA), was raised in HeLa cells and purified on CsCl gradients. The viral genomic DNA was isolated by Proteinase K digestion. The genomic DNA was subsequently digested by various kinds of restricted endonucleases to construct the restricted endonuclease map (Figure 1a ). We found that there were no SbfI and NotI recognition sites in the Ad35 genome. The viral DNA was digested with PacI after ligation of the SbfI linker, and then the 2.8-3.0 kb left end fragment was purified from the agarose gel. The purified fragment was cloned into SbfI and PacI sites of a shuttle plasmid pFS2, which contained a multicloning site composed of SbfI/SwaI/ PacI/AscI/SgfI/NotI sites, creating pFS2-Ad35-5. pFS2 was constructed by ligation of XbaI/SacI-digested pGEM7Zf(+) (Promega Corp., Madison, USA) with the oligonucleotides containing the multicloning site. The viral DNA was also digested with EcoRI after ligation of the NotI linker, and then the 7.0-7.3 kb right end fragment was recovered. The purified fragment was cloned into the EcoRI and NotI sites of pHM15, 11 creating pHM15-Ad35-1.
Subsequently, pHM15-Ad35-1 was digested with BamHI and NotI, and the fragment (about bp 30 300 -right end of the genome) was cloned into the BamHI and NotI sites of pFS2-Ad35-5, resulting in pFS2-Ad35-6. Escherichia coli BJ5183 (recBC and sbcBC) (Qbiogene, Inc., Carlsbad, CA, USA) was cotransformed with BamHIlinearized pFS2-Ad35-6 and the purified Ad35 DNA by electroporation. A plasmid containing a full-length Ad35 genome flanked by SbfI and NotI sites (pAdMS1) was constructed by homologous recombination. The correct structure of pAdMS1 was verified by restriction enzyme analysis. Digestion of pAdMS1 with BamHI, SbfI, and NotI produced the expected fragments as shown in Figure 2 .
The E1 region in the Ad35 genome was modified using pFS2-Ad35-5 ( Figure 1b) . The PacI/AscI fragment (about bp 2900-8400) of the Ad35 genome was ligated with a PacI/AscI fragment of pFS2-Ad35-5, after the AccI/PacI fragment (about bp 400-2900, which should correspond to E1a and E1b) of the Ad35 genome in pFS2-Ad35-5 was deleted, and the AccI site of pFS2-Ad35-5 was changed into a PacI site, resulting in pFS2-Ad35-7. pFS2-Ad35-7 contained the left end of the Ad35 genome (bp 1-8400) with the deletion of the E1 region (D bp about 400-2900). A BglII fragment of pHMCMV-GFP1, 12 which contained the CMV promoter, the green fluorescent protein (GFP) gene (derived from pEGFP-N1 (Clontech, Palo Alto, CA, USA)), and the bovine growth hormone (BGH) p(A) gene, was cloned into the PacI site of pFS2-Ad35-7 after the BglII site of pHMCMV-GFP1 was changed into a PacI site. The resulting plasmid was named pFS2-Ad35-7-GFP1. The SbfI/AscI fragment of pFS2-Ad35-7-GFP1, which contains the GFP expression cassette, was subsequently exchanged with an SbfI/AscI fragment of pAdMS1, resulting in pAdMS1-GFP1 (Figure 1b) . Ad35 vector plasmid containing a CMV promoter-driven luciferase expression cassette was constructed similarly, except that the luciferase expression cassette was cloned in reverse orientation.
GFP-expressing Ad35 vector, Ad35GFP, was generated by the transfection of SbfI/NotI-digested pAdMS1-GFP1 into VK10-9 cells 13 (kindly provided by Dr V Krougliak), which are 293 cells expressing the E4 proteins of Ad5 as well as the E1 proteins. A cytopathic effect (CPE) was observed 10-14 days after transfection, and the virus was then amplified in VK10-9 cells and purified by the conventional method for Ad5 vector. The final virus yield prepared from seven plates of 150-mm dishes was approximately 1.5 ml of virus at 10 11 vector particle (VP)/ml, which was similar to or slightly less than the yield in the case of Ad5 vector preparation. Luciferase- The expected DNA fragments were detected by BamHI or SbfI/NotI/BamHI digestion. Ad5 vector and Ad5F35 vector containing a GFP (Ad5GFP, Ad5F35GFP) or luciferase expression cassette (Ad5L, Ad5F35L) was constructed as previously described. 10, 14 We confirmed that the DNA sequence of the fiber shaft and the knob of the Ad35 vectors was the same as that of the Ad5F35 vectors. Determination of the infectious (plaque forming unit: PFU) titer and particle titer of Ad35, Ad5F35, and Ad5 vectors was accomplished using VK10-9 cells by the method of Kanegae et al 15 and the method of Maizel et al 16 , respectively. The PFU-to-particle ratio was 1:133 for Ad35GFP, 1:24 for Ad5F35GFP, 1:56 for Ad5GFP, 1:225 for Ad35L, 1:13 for Ad5L, and 1:13 for Ad5F35L. The lower PFU-to-particle ratio of Ad35GFP and Ad35L may reflect that subgroup B viruses often have PFU-toparticle ratios 10-fold lower than those of subgroup C. 17 We did not observe CPE when SbfI/NotI-digested pAdMS1-GFP1 was transfected into 293 cells. It appeared that 293 cells were not able to fully complement the replication of the E1-deleted Ad35 vector, although even the replication-defective chimpanzee Ad vector was successfully amplified in 293 cells. 18 It remains unclear as to which proteins expressed in VK10-9 cells are essential to the generation of Ad35 vector. Abrahamsen et al 19 have reported that replication-incompetent Ad7a vector can be isolated from 293-ORF6 cells, but not 293 cells, which express the E4 open reading frame (ORF) 6 gene products of Ad5. VK10-9 cells also contain the sequence encoding the E4 ORF6 (Ad5 bp 33 190-34 084). The E4 proteins are involved in the regulation of cellular and viral gene expression, viral DNA replication, late viral RNA accumulation, viral protein synthesis, host shutoff, virus assembly, E2 expression, and adenoassociated virus helper function. [20] [21] [22] [23] Of the possible ORF products encoded by the E4 region, the E4 ORF3 and ORF6 could compensate for deficiencies in each other and have been shown to control late viral mRNAs at a post-transcriptional level by increasing the nuclear stability of pre-mRNAs transcribed from the major late promoter. 24, 25 Either the E4 ORF3 or the E4 ORF6 gene products are absolutely required for viral growth of Ad5 and can substitute for the entire E4 region. 20, 26 The E4 proteins of Ad5, especially the E4 ORF6 gene products, might assist in the replication of the E1-deleted Ad35 vector in 293 cells expressing the E1 gene products of Ad5 when the 293 cells are used as packaging cell lines.
Precise information regarding the sequence of Ad35 E1 is not yet available. We deleted an approximately 2.5-kb fragment (about bp 400-2900), which should correspond to E1a and E1b as compared with the sequence of Ad5 E1. Amplification of the recombinant Ad35 vectors was not observed in cultured cell lines, except for 293 cells expressing the E4 gene products of Ad5 (VK10-9 cells), indicating that the E1 region of the Ad35 genome in the vector presented in this study, which is essential for viral amplification, would be deleted.
Transduction in human CD34

+ -enriched bone marrow cells
We evaluated the transduction efficiency in human CD34 + cells with the Ad35 vector, and compared the efficiency with that with the conventional Ad5 vector and the fiber-substituted Ad5F35 vector. Human CD34 + cells (Biowhittaker, Inc., Walkersville, MD, USA) were recovered from the frozen stock, suspended in StemSpant 2000 containing cytokine cocktail StemSpant CC100 (human Flt-3 ligand (100 ng/ml), human stem cell factor (100 ng/ml), human interleukin-3 (20 ng/ml), and human interleukin-6 (20 ng/ml)) (StemCell Technologies Inc., Vancouver, BC, Canada), and were seeded into a 24-well plate (1 Â 10 5 cells/well). Cells were transduced with the GFP-expressing Ad vectors (3, 30 , 300 PFU/cell) 16-18 h after seeding. At 48 h after transduction, GFP expression in the cells was analyzed by flow cytometry on a FACSCalibur flow cytometer using CellQuest software (Becton Dickinson, Tokyo, Japan). As shown previously, [7] [8] [9] Ad5F35GFP transduced CD34 + cells more efficiently than Ad5GFP, but Ad35GFP was more efficient than Ad5F35GFP (Figure 3) . We found signifi- (Figure 3b ). At 300 PFU/cell, 53% of CD34 + cells expressed GFP by transduction with Ad35GFP. In contrast, the conventional Ad5GFP and chimeric Ad5F35GFP conferred GFP expression to 5% and 52% of CD34 + cells, respectively. These results suggest that Ad35GFP delivered greater amounts of GFP gene into the CD34 + cells than Ad5GFP and Ad5F35GFP, although the percentages of GFP-positive cells were similar between Ad35GFP and Ad5F35GFP.
We also examined the transduction efficiency with Ad35 vector containing a luciferase expression cassette (Figure 4 ). In the case of luciferase expression, human CD34 + cells were seeded into a 96-well dish (1 Â 10 4 cells/well). These cells were transduced by each Ad vector 16-18 h after seeding, and 48 h after transduction luciferase expression in the cells was evaluated using a luciferase assay system (PicaGene LT2.0; Toyo Inki, Tokyo, Japan). Transduction with Ad35L, which has a luciferase expression cassette, also exhibited 1000-3000 times and 15-100 times higher luciferase production in human CD34
+ cells than transduction with Ad5L and Ad5F35L, respectively (Figure 4a) .
We performed the transduction experiment described above at the constant PFU/cell of each Ad vector. We may have underestimated the PFU titer of Ad35 vectors, however, because 293 cells expressing the E4 gene products might not fully complement the replication of Ad35 vectors as they do for Ad5 vectors. Therefore, we also examined the transduction efficiency at the constant VP/cell and found that Ad35L also showed higher transduction efficiency than Ad5L and Ad5F35L at more than 3000 VP/cells (Figure 4b) . A higher transduction efficiency with Ad35 vectors than with the other vectors was also observed in all the human CD34 + cells from three different donors (data not shown). We also confirmed that the different batch of Ad35L showed higher transduction efficiencies in human CD34 + cells than Ad5L and Ad5F35L (data not shown). The transduction efficiencies of Ad5, Ad5F35, and Ad35 vectors in various types of cells were also examined. In CAR-positive cells (SK HEP-1, A549, HeLa), the Ad5 vectors showed higher transduction efficiencies than Ad35 vectors at the constant VP/cell (data not shown).
Next, to examine the vector toxicity of each Ad vector on the CD34 + cells, we evaluated the viabilities of human CD34 + cells transduced with the Ad vectors by trypan blue exclusion. More than 80% of the cells were viable at all concentrations of the Ad vectors, although slight toxicities were observed by Ad5F35GFP and Ad35GFP at 300 PFU/cell ( Figure 5 ). These results are consistent with those reported previously by Stecher et al. 27 They developed the fiber-substituted Ad5 vector containing fiber proteins of Ad11 (Ad5F11), which belongs to subgroup B and has a high affinity to human CD34 + cells than the Ad5 vectors. However, the data presented here show that the Ad35 vectors, which were composed of the whole Ad35, transduced human CD34 + cells more efficiently than the fiber-substituted Ad5F35 vectors. It remains unclear as to which components of Ad35 play an important role in efficient infection into human CD34 + cells. Our data, however, suggest that not only fiber proteins, but also other capsid proteins are important. Considering that a penton base is largely involved in endosomal lytic activity, 28, 29 a penton base of Ad35 may also be involved in the efficient infection of Ad35 vectors into human CD34 + cells. The virus-cell interaction mediated through penton bases varies according to serotype. 30, 31 Viral escape from the endosome may involve distinct mechanisms of vesicle disruption in a serotype-dependent manner. 17, 29 The amino-acid sequence of the central region of a penton base is highly variable between serotypes, while the amino-acid sequences of N-and Cterminal regions of the penton base are similar. 32 The central region of the penton base is exposed on the surface of the virion and contains the RGD sequence in Ad2, Ad3, Ad4, Ad5, and Ad12.30, 32 30, 32 Ad35 might have a specific amino-acid sequence in the central region of the penton base that might be involved in the efficient infection into human CD34 + cells. We found that luciferase production by Ad5L, Ad5F35L, and Ad35L was decreased by 50-60% in the presence of 400 mg/ml RGD peptide in human CD34 + cells (data not shown), suggesting that some types of integrins might be involved in the transduction with Ad35 vectors as well as Ad5 and Ad5F35 vectors into human CD34 + cells. However, the interaction of cells with fibronectin, which has an RGD sequence, may trigger intracellular signaling pathways affecting cell survival and proliferation. 33, 34 Some intracellular signaling may inhibit the transduction efficiencies of Ad35 vectors. The precise mechanism for the effect of the penton base on Ad35 vector-mediated gene transfer might become clear after the sequence of Ad35 genome has fully determined.
On the other hand, fiber proteins have been shown to modulate the intracellular trafficking of Ad as well as the binding to cells. [35] [36] [37] Shayakhmetov et al 37 have reported that the intracellular trafficking of Ad5F35 vectors is different from that of Ad5 vectors. A significant amount of the Ad5F35 vector is localized in the late endosome and lysosome, while the majority of the Ad5 vector is readily moved to the perinuclear space after endocytosis. A similar phenomenon has also been observed when A549 cells are infected with Ad5, Ad7, and Ad5F7. 35, 36 Ad5F7 contains the fiber shaft and knob of Ad7, which belongs to subgroup B, instead of the Ad5 fiber shaft and knob, in the Ad5 capsid. Ad5 was observed to escape rapidly from the endosome after internalization and to be translocated to the nucleus within 1 h. In contrast, Ad7 and Ad5F7 accumulated in the acidic compartment, which was supposed to be late endosome and lysosome, and translocated to the nucleus more slowly than Ad5, although accumulation of Ad7 vectors in the late endosome and lysosome would not impair the transduction efficiencies in comparison with Ad5 vectors. 19, 35, 36 Ad35 vectors might also behave similar to Ad5F35, not Ad5. Ad35 and Ad5F35 vectors might accumulate in the late endosome and lysosome and move slowly to the nucleus.
It is possible, but unlikely, that capsid proteins or other Ad35 viral proteins might have a more positive effect on the activity of the CMV promoter than those of Ad5. The left ITR and the E1a enhancer in the Ad5 genome affect the transcription activities of the promoter cloned in the E1 region. 38, 39 It is possible that the left ITR and the E1a enhancer in the Ad35 genome enhance the transcription activities of the promoter cloned in the E1 region in human CD34
+ cells. In this study, the luciferase expression cassette was inserted in reverse orientation, while the GFP expression cassette was inserted in forward orientation. Both Ad35 vectors showed higher transduction efficiencies than the other types of Ad vectors, suggesting that the higher transduction efficiencies of the Ad35 vectors in human CD34 + cells are not primarily because of the influence of the left ITR and the E1a enhancer on the promoter activity.
The transduction efficiency with Ad5F35GFP in this study was similar to that reported previously by other researchers. 7, 9 Some studies, however, have found a considerably higher transduction efficiency with the conventional Ad5GFP than our data presented here. 7, 40 Shayakhmetov et al 7 have reported that 10-20% of CD34 + cells are GFP-positive after transduction with the conventional Ad5 vector expressing GFP at more than 50 PFU/cell. In contrast, several groups have reported no or only negligible levels of transduction when human CD34 + cells are transduced with the Ad5 vector. 41, 42 It has also been reported that the percentage of GFPexpressing cells depends on the donor and varies from 0% to 30% after transduction with the conventional Ad5 vector in human CD34 + cells. 9 The extent of the transduction efficiency with the Ad5 vector in human CD34 + cells is controversial. The transduction efficiency with the conventional Ad5 vectors in human CD34 + cells would largely depend on the culture conditions, including the presence or absence of cytokines, specimens of CD34 + cells, and experimental conditions. Larger differences in the transduction efficiencies of each Ad vector expressing luciferase were observed in comparison with the Ad vectors expressing GFP ( Figures  3 and 4) . We considered that the differences between the transduction efficiencies of Ad vectors expressing GFP and those of Ad vectors expressing luciferase were primarily because of the sensitivity of the assay. We also confirmed the presence of larger differences in the levels of luciferase expression compared with the levels of GFP expression in the other cell lines when conventional and fiber-modified Ad vectors were used (data not shown). The orientation of transgene expression cassettes may partly explain the differences in the transduction efficiencies, as the left ITR and the E1a enhancer in the Ad5 genome affect the transcription activities of the promoter cloned in the E1 region. 38, 39 In the vectors presented in this study, the GFP expression cassette was cloned in forward orientation, while the luciferase expression cassette was cloned in reverse orientation.
It might be necessary to improve the Ad35 vectors for a more widespread application. For example, the Ad vectors devoid of all viral genes allow for transduction of human hematopoietic cells without immune responses against the Ad proteins expressed in transduced cells.
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Ad vectors do not integrate viral genomes into the host genome, which limits the persistence of transgene expression in HSCs. To address this problem, several groups have developed hybrid adenovirus/adeno-associated virus vectors, which have the ability to integrate viral genomes into the host genome. [43] [44] [45] Ad35 would become a promising framework vector for the development of these improved vectors for efficient gene transfer into HSCs.
Identification of the fraction of CD34 + cells transduced with Ad35 vectors is an important issue. It is well known that the HSCs constitute only a fraction of the CD34 + cells. Ad5F35 vectors have been reported to transduce the subsets with potential stem cell capacity, 7, 9 although the transduction inhibits cell proliferation and colony formation. 43 Since Ad35 contains fiber proteins identical to those of Ad5F35 and mediates similar levels of GFPpositive cells, we expect that Ad35 vectors would also transduce the fractions of human CD34
+ cells with stem cell capacity.
The present results demonstrate that Ad vectors composed of whole Ad35 can transduce human CD34 + cells more efficiently than the conventional Ad5 vector and the fiber-substituted Ad5F35 vector. To our knowledge, this is the first report of the generation of the E1 (both E1a-and E1b-)deleted Ad35 vector. The Ad35 vector shows promise as a tool for gene therapy and the study of gene function in HSCs. Since Ad35 and Ad5 belong to different subgroups, the use of Ad35 may allow researchers to avoid the antibody response against Ad5. In that case, the Ad35 vector would be an effective alternative for use in the second injection when the Ad5 vector is used in the first injection of in vivo gene therapy.
